268 related articles for article (PubMed ID: 30710584)
1. Ribophorin II potentiates P-glycoprotein- and ABCG2-mediated multidrug resistance via activating ERK pathway in gastric cancer.
Zhang H; Jiang H; Zhang H; Liu J; Hu X; Chen L
Int J Biol Macromol; 2019 May; 128():574-582. PubMed ID: 30710584
[TBL] [Abstract][Full Text] [Related]
2. DJ-1 is involved in the multidrug resistance of SGC7901 gastric cancer cells through PTEN/PI3K/Akt/Nrf2 pathway.
Qiu L; Ma Z; Li X; Deng Y; Duan G; Zhao LE; Xu X; Xiao L; Liu H; Zhu Z; Chen H
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1202-1214. PubMed ID: 33079995
[TBL] [Abstract][Full Text] [Related]
3. Reversal of P-glycoprotein-mediated multidrug resistance in SGC7901/VCR cells by PPARgamma activation by troglitazone.
Chen Q; Zhou J; Jiang C; Chen J
J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):326-31. PubMed ID: 20556576
[TBL] [Abstract][Full Text] [Related]
4. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells.
Hao Z; Li X; Qiao T; Du R; Hong L; Fan D
Cancer Biol Ther; 2006 Mar; 5(3):261-6. PubMed ID: 16410721
[TBL] [Abstract][Full Text] [Related]
5. Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells.
Guo X; Ma N; Wang J; Song J; Bu X; Cheng Y; Sun K; Xiong H; Jiang G; Zhang B; Wu M; Wei L
BMC Cancer; 2008 Dec; 8():375. PubMed ID: 19091131
[TBL] [Abstract][Full Text] [Related]
6. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
[TBL] [Abstract][Full Text] [Related]
7. Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo.
Guo X; To KKW; Chen Z; Wang X; Zhang J; Luo M; Wang F; Yan S; Fu L
J Exp Clin Cancer Res; 2018 Feb; 37(1):31. PubMed ID: 29458405
[TBL] [Abstract][Full Text] [Related]
8. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
[TBL] [Abstract][Full Text] [Related]
9. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone.
Li DQ; Wang ZB; Bai J; Zhao J; Wang Y; Hu K; Du YH
World J Gastroenterol; 2004 Jun; 10(12):1722-5. PubMed ID: 15188493
[TBL] [Abstract][Full Text] [Related]
10. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.
Guan J; Chen XP; Zhu H; Luo SF; Cao B; Ding L
World J Gastroenterol; 2004 Dec; 10(23):3522-7. PubMed ID: 15526378
[TBL] [Abstract][Full Text] [Related]
11. DJ-1 overexpression confers the multidrug resistance phenotype to SGC7901 cells by upregulating P-gp and Bcl-2.
Liu HY; Duan GL; Xu RY; Li XR; Xiao L; Zhao L; Ma ZX; Xu XW; Qiu LJ; Zhu ZM; Chen HP
Biochem Biophys Res Commun; 2019 Oct; 519(1):73-80. PubMed ID: 31477270
[TBL] [Abstract][Full Text] [Related]
12. AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway.
Lian W; Zhang L; Yang L; Chen W
Apoptosis; 2017 Jul; 22(7):933-941. PubMed ID: 28439677
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
[TBL] [Abstract][Full Text] [Related]
14. LncRNA DANCR accelerates the development of multidrug resistance of gastric cancer.
Xu YD; Shang J; Li M; Zhang YY
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2794-2802. PubMed ID: 31002130
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of ZNRD1 promotes multidrug-resistant phenotype of gastric cancer cells through upregulation of P-glycoprotein.
Shi Y; Zhang Y; Zhao Y; Hong L; Liu N; Jin X; Pan Y; Fan D
Cancer Biol Ther; 2004 Apr; 3(4):377-81. PubMed ID: 14726695
[TBL] [Abstract][Full Text] [Related]
16. Midkine confers Adriamycin resistance in human gastric cancer cells.
Xu YY; Mao XY; Song YX; Zhao F; Wang ZN; Zhang WX; Xu HM; Jin F
Tumour Biol; 2012 Oct; 33(5):1543-8. PubMed ID: 22576950
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines.
Wang Y; Zhang D; Wu K; Zhao Q; Nie Y; Fan D
Mol Cell Biol; 2014 Sep; 34(17):3182-93. PubMed ID: 24958102
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer resistance protein/ABCG2 is differentially regulated downstream of extracellular signal-regulated kinase.
Imai Y; Ohmori K; Yasuda S; Wada M; Suzuki T; Fukuda K; Ueda Y
Cancer Sci; 2009 Jun; 100(6):1118-27. PubMed ID: 19514121
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
[TBL] [Abstract][Full Text] [Related]
20. Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo.
Chen M; Huang SL; Zhang XQ; Zhang B; Zhu H; Yang VW; Zou XP
J Cell Biochem; 2012 Jul; 113(7):2474-87. PubMed ID: 22396185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]